Internal Medicine Alert – September 30, 2021
September 30, 2021
View Issues
-
Combined GIP/GLP-1 Agonist: Safe for Type 2 Diabetes Patients?
In the SURPASS-2 trial, tirzepatide showed noninferiority and superiority vs. semaglutide in decreasing A1c levels in patients with type 2 diabetes.
-
Asymptomatic Transmission of COVID-19 in Households
Efforts to control secondary transmission should be given to households and those contact groups where any case of secondary transmission has been identified.
-
Fermented Foods Help the Immune System, Alleviate Inflammation
A diet rich in fermented foods from dairy and other sources reduced 19 inflammatory markers compared with a high-fiber diet.
-
Vitamin and Mineral Supplements for Cardiovascular Disease
A meta-analysis of systematic reviews and randomized, controlled trials to analyze the role of commonly used dietary supplements for prevention and treatment of cardiovascular disease suggests no significant effect on cardiovascular outcomes or all-cause mortality, although some B vitamins appear to reduce stroke incidence, and B3 appears to increase all-cause mortality.
-
Functional Cognitive Disorder: An Important Condition to Recognize
Functional cognitive disorder (FCD) can describe cognitive difficulties that are present where there is no biologic cause, but a lack of consensus in diagnostic criteria limits its use in clinical practice and research. The authors proposed an operational definition for FCD as the cognitive phenotype of functional neurological disorder.
-
COVID-19 Vaccine mRNA Injection (Comirnaty)
Comirnaty is the first COVID-19 vaccine to receive full FDA approval.